Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • China
  • Coronavirus Infections / complications*
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / mortality
  • Coronavirus Infections / pathology
  • Disease Progression*
  • Hospitalization / statistics & numerical data*
  • Humans
  • Lymphocytes / metabolism
  • Lymphocytes / pathology
  • Lymphopenia / complications*
  • Lymphopenia / diagnosis*
  • Lymphopenia / pathology
  • Pandemics
  • Peptidyl-Dipeptidase A / metabolism
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / mortality
  • Pneumonia, Viral / pathology
  • Practice Guidelines as Topic
  • Prognosis
  • Reproducibility of Results
  • SARS-CoV-2
  • Time Factors

Substances

  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2